Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis

INTRODUCTION: The once-daily long-acting muscarinic antagonist (LAMA) tiotropium and once-daily long-acting β(2)-agonist (LABA) olodaterol have been studied as a once-daily fixed-dose combination (FDC) in patients with chronic obstructive pulmonary disease (COPD). Two large, 52-week, double-blind, p...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Adv Ther
Main Authors: Ferguson, Gary T., Fležar, Matjaž, Korn, Stephanie, Korducki, Lawrence, Grönke, Lars, Abrahams, Roger, Buhl, Roland
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2015
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486785/
https://ncbi.nlm.nih.gov/pubmed/26112656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-015-0218-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker